Related Experiment Video
Updated: May 8, 2026

Transdermal Measurement of Glomerular Filtration Rate in Mechanically Ventilated Piglets
Published on: September 13, 2022
A randomised controlled trial of plasma filtration in severe paediatric sepsis
Elliot J Long1, Anna Taylor, Carmel Delzoppo
1Royal Children's Hospital, Melbourne, VIC, Australia. elliot.long@rch.org.au
Insights
Plasma filtration did not significantly improve 28-day survival in children with severe sepsis. This study was underpowered due to poor recruitment, but found no significant difference in mortality between groups.
Area of Science:
- Pediatric critical care medicine
- Sepsis research
- Extracorporeal therapies
Background:
- Severe sepsis in children is a life-threatening condition.
- Standard therapy for septic shock has limitations.
- Plasma filtration is a potential adjunctive treatment.
Purpose of the Study:
- To evaluate if plasma filtration improves 28-day survival in pediatric severe sepsis.
- To assess the impact of plasma filtration on organ system failure and mortality.
Main Methods:
- A multicenter randomized controlled trial involving 48 infants and children with severe sepsis.
- Patients were assigned to plasma filtration or standard therapy.
- Primary outcome was 28-day survival; secondary outcomes included organ failure and functional status.
Main Results:
- The trial was halted early due to insufficient recruitment.
- Plasma filtration group had higher initial disease severity.
- No significant difference in 28-day mortality was observed between groups after adjusting for illness severity.
Conclusions:
- The study was underpowered to determine the efficacy of plasma filtration for severe sepsis in children.
- Plasma filtration did not demonstrate a significant survival benefit in this trial.
- Further research with adequate patient numbers is needed.
Objective:
To determine whether plasma filtration improves 28-day survival in infants and children with severe sepsis.
Design:
A multicentre randomised controlled trial.
Setting:
Paediatric intensive care units in teaching hospitals.
Patients:
Forty-eight infants and children with severe sepsis.
Interventions:
Patients were randomly assigned to receive plasma filtration (n = 25) or standard therapy (n = 23) for the treatment of septic shock. The primary outcome measure was 28-day survival. Secondary outcome measures included the number of failed organ systems on Day 7, a requirement for extracorporeal membrane oxygenation (ECMO), and the modified Glasgow outcome score (MGOS) at 6 months (where 1 is normal and 6 is dead).
Results:
The trial was stopped early due to poor recruitment. Patients in the plasma filtration group had higher initial disease severity as measured by serum lactate level, inotrope score and MGOS. Ten (40%) children died in the plasma filtration group and 4 (17%) died in the control group. With intention-to-treat analysis and adjustment for lactate level, ventilation index, inotrope score and MGOS at admission using logistic regression, the odds ratio for death with plasma filtration was 1.20 (95% CI, 0.23-6.20; P = 0.82). The median number of failing organ systems at 7 days was 2 (interquartile range [IQR], 1-4) in the plasma filtration group versus 2 (IQR, 1-3) in the control group. Two children in the plasma filtration group required ECMO for 2.5 and 123 hours, and one child in the control group required ECMO for 45 hours. The median MGOS at 6 months was 4 (IQR, 2-6) in the plasma filtration group and 2 (IQR, 1-4) in the control group.
Conclusions:
Our study did not recruit enough patients to test the hypothesis that addition of plasma filtration to our standard care protocol reduces 28-day mortality in children with severe sepsis. However, mortality in the treatment and control groups was not significantly different after adjustment for severity of illness at the time of randomisation.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Continuous Renal Replacement Therapy
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
